Anticancer effect of different extracts of Cynanchum acutum L. seeds on cancer cell lines
Ahmed Mohamed Mohamed Youssef1, Zeinab Ahmed Said El-Swaify2, Yousef Mohammed Al-Saraireh3, Saed Mohammed Al-Dalain3
1 Department of Pharmacology, Faculty of Pharmacy, Mutah University, Mutah, Karak, Jordan
2 Department of Botany, Faculty of Science, Al-Azhar University, Cairo, Egypt
3 Department of Pharmacology, Faculty of Medicine, Mutah University, Mutah, Karak, Jordan
|Date of Submission||02-Jan-2019|
|Date of Decision||12-Feb-2019|
|Date of Web Publication||23-Aug-2019|
Ahmed Mohamed Mohamed Youssef
Department of Pharmacology, Faculty of Pharmacy, Mutah University, P.O. Box: 7, Mutah, Karak 61710
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Cynanchum acutum L. is a perennial medicinal herb, used for several traditional medicine purposes in Egypt and around the world. Objective: The anticancer effects of ether, chloroform subfraction, and aqueous extracts of C. acutum seeds were investigated. Materials and Methods: C. acutum seeds were extracted by ether, chloroform, and aqueous. Then, all extracts were subjected to gas chromatography/mass spectrometry (GC/MS) to determine alkaloids and other bioactive compounds. Furthermore, anticancer effects on malignant cell lines as well as normal cells were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results: GC/MS analysis of the different extracts of C. acutum seeds revealed different compounds of alkane hydrocarbons, fatty acids, sterols, terpenoids, flavonoids, and alkaloids. The significant components of unsaturated fatty acids were linoleic acid (56.71%) in the ether extract and oleic acid (6.59%) in the chloroform extract, whereas the major saturated fatty acid was palmitic acid (3.51%) in the ether extract. Furthermore, the anticancer effects of the three extracts of the plant seeds on all tested cancer cell lines were minor. However, the higher anticancer effects were observed on lung (A549) and breast (MCF-7) cancers by water and ether extracts, respectively, as compared to positive control. Furthermore, both extracts showed low cytotoxicity toward normal cell line (WI-38) comparing to a positive control. Conclusion: Aqueous and ether extracts of C. acutum L. seeds could be considered as potential chemotherapeutic agents in lung and breast cancer treatments, respectively, with reduced systemic adverse effects.
Keywords: Alkaloids, breast cancer, Cynanchum acutum, flavonoids, gas chromatography/mass spectrometry, lung cancer
|How to cite this article:|
Mohamed Youssef AM, Said El-Swaify ZA, Al-Saraireh YM, Al-Dalain SM. Anticancer effect of different extracts of Cynanchum acutum L. seeds on cancer cell lines. Phcog Mag 2019;15, Suppl S2:261-6
|How to cite this URL:|
Mohamed Youssef AM, Said El-Swaify ZA, Al-Saraireh YM, Al-Dalain SM. Anticancer effect of different extracts of Cynanchum acutum L. seeds on cancer cell lines. Phcog Mag [serial online] 2019 [cited 2021 May 6];15, Suppl S2:261-6. Available from: http://www.phcog.com/text.asp?2019/15/64/261/265034
- In gas chromatography/mass spectrometry evaluation of Cynanchum acutum seeds, dihydrovallesiachotamine, voacristine hydroxyindolenine, pseudojervine, 6,7-dihydro-neblininane, aspidofractinine-3-methanol, phytol, cedrene, oleic acid, linoleic acid, lucenin-2, and quercetin 7, 3, 4-trimethoxy were identified as anticancer agents from previously reported literature. Aqueous and ether extracts of Cynanchum acutum seeds possessed highly anticancer effects on lung cancer cell line (A549) and breast cancer cell lines (MCF-7), respectively, whereas chloroform extract demonstrated low anticancer activity against all studied cancer cell lines comparing to a positive control. Aqueous, ether, and chloroform extracts showed low cytotoxicities against normal cell lines (WI-38) as compared to a positive control.
Abbreviations used: MTT: 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; Eth: Ether extract; Chl: Chloroform extract; Aqu: Aquatic extract of seeds.
| Introduction|| |
Recently, medicinal plants are being investigated for promising new drugs in cancer treatment. Cynanchum acutum L., Asclepiadaceae, is a medicinal climber herb. It is found around canal bank edges of cultivation areas of the River Nile and Mediterranean regions. It is used traditionally in Egypt and around the world for the treatment of various diseases, including skin diseases, pimples, skin ulcers, diabetes, and bacterial infections. It exhibited anticancer effects against colon cancer cell line (HCT-116) and hepatocellular carcinoma cell line (HepG2). Furthermore, Estakhr et al. (2012) reported that this plant has an anti-inflammatory effect. The phytochemical investigations on C. acutum have revealed the presence of several natural compounds including β-sitosterol, lupeol, lupyl acetate, and α-amyrin; four flavonoid glycosides  as well as seven flavonoids; acylated flavonoid diglycosides; and two simple coumarins such as scopoletin and scoparone. Some species of genus Cynanchum which have close affiliations with C. acutum possessed bioactive compounds such as novel triterpene, sinapic acid esters and phenolic glycoside, alkaloids,,, pregnane sapogenins, carbohydrates, steroidal glycosides, and flavonoid compounds. The medicinal importance of the seeds alone of C. acutum has not been investigated. Furthermore, the bioactive compounds that are in the seeds only have not been reported in the literature. We previously investigated the anticancer effects of the methanol extract of C. acutum seeds on different cancer cell lines. The data showed potential anticancer activities against all studied cancer cell lines. Furthermore, we identified several bioactive compounds in the methanol extract of the seeds alone. We reported that seventeen phenolic acids and nineteen flavonoids were identified and quantified in the methanol extract of C. acutum seeds. Kaempferol-3-glucoside-2”-P-coumaroyl was a flavonoid identified for the first time. However, the different extracts of the seeds have not been investigated. Thus, this study aims to focus on the identification and quantification of new bioactive compounds of the different extracts (ether, chloroform, and aqueous) of C. acutum seed extracts and their anticancer effects against various cancer cell lines.
| Materials and Methods|| |
The seeds of C. acutum were collected from November to December 2017 from the Damietta Branch of the River Nile, Egypt. The plant was kindly authenticated by Plant Taxonomist, Professor Iman Al-Gohary, Department of Plant Ecology and Range, Desert Research Centre, Cairo, Egypt, and a voucher specimen was kept at the Herbarium of the Centre with code number (CAIH-0005R).
Extraction of plant seeds
Seeds were separated, washed, dried in shade, and ground to fine powder. One hundred grams of powdered C. acutum seeds was extracted with diethyl ether (500 ml 3× times) by cold percolation method on a shaker for 72 h. The ether extract was filtered in a Buchner funnel. After the removal of ether in a rotary evaporator at a temperature below 40°C, the residue was dried in a dissector to obtain the ether crude Ether extract (Eth). The finely powdered seeds were thoroughly moistened with 28% NH4 OH solution (pH = 9) and then were dried. The seed powder was percolated with methanol for 72 h (300 ml 3×) on a shaker. The extract filtered was neutralized with HCl (1%) and evaporated to its half volume and then extracted three times with chloroform (25 ml) in a separatory funnel. The resulting chloroform extract was dried and evaporated to obtain the alkaloid compounds in chloroform crude (Chl). The resulting aqueous extract was dried and evaporated to obtain the aqueous crude (Aqu). The crudes of ether, chloroform, and aqueous extracts were subjected to GC/MS to determine the alkaloids and other bioactive compounds.
Gas chromatography/mass spectrometry
The samples of C. acutum L. seeds were analyzed by gas chromatography/mass spectrometry (GC-MS) (Shimadzu GC/MS-QP 5050A) instrument using a DBI column (30 mm × 0.25 mm ID × 0.25 μm, film thickness). Constant flow at 1 ml/min of carrier gas (Helium) was used for sample analysis. The injector temperature of the instrument was programmed at 280°C. Oven temperature was started from 40°C to 280°C with a ramp of 2°C/min and withholding time of 7.5 min. The injection volumes were 1 μl. The temperature of the ion source was set at 280°C. Ionization of the sample was performed in electron impact mode at an ionization voltage of 70 eV with mass range used from m/z 50-650. Interpretation of GC-MS data was performed using the database of Wiley and Nist libraries.
Lung cancer (A549), prostate cancer (PC3), breast cancer (MCF-7), hepatocellular carcinoma (HepG-2), colon cancer (Caco-2), and normal human fetal lung fibroblast (WI-38) were obtained from tissue culture laboratory, Vacsera, Dokkey, Giza, Egypt.
Culturing of cell lines
Laminar air flow cabinet was used to maintain the sterility of the procedure. The cell culture was maintained in Roswell Park Memorial Institute medium (RPMI 1640). It contained 1% antibiotic–antimycotic mixture (10,000 μg/ml streptomycin sulfate, 25 μg/ml amphotericin B, and 10,000 U/ml potassium penicillin) and 1% L-glutamine. Fetal bovine serum (10% heat-inactivated) was used to supplement the medium. Culturing and subculturing were performed according to Thabrew et al.
In vitro cytotoxicity assay
The cytotoxicity was evaluated by the mitochondrial-dependent reduction of yellow 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT). The yellow MTT undergoes a mitochondrial reduction to form a purple formazan. The 96-well tissue culture microplate was inoculated at a cell concentration of 1 × 105 cells per well in 100 μl of growth medium. The microplate was incubated at 37°C (5% CO2) for 24 h to develop a complete monolayer sheet. Growth medium was decanted from 96-well microplate after the formation of the confluent layer of cells. The extract of the seeds was dissolved in dimethyl sulfoxide (DMSO). Serial dilutions of the dissolved extract were prepared by RPMI–1640 medium to give a final concentration of 1000, 500, 250, 125, 62.5, 31.25, and 15.625 μg/ml. 0.1 ml of each concentration of the extract was added to confluent cell monolayers dispensed into 96-well microplate using a multichannel pipette. The treated cells were incubated at 37°C (5% CO2) for 24 h. Three wells were used for each concentration of the extract. Control cells were incubated without the seeds extract. MTT powder was dissolved in phosphate-buffered solution (Bio Basic Canada Inc.,) to give a solution at the concentration of 5 mg/ml. After the end of the incubation period, 20 μl of the MTT solution was added to each well. The mixing was allowed at 150 rpm for 5 min using the shaker. Then, the 96-well microplate was incubated at 37°C (5% CO2) for 4 h to allow the MTT metabolism. Formazan (MTT metabolic product) was resuspended in 200 μl of DMSO and placed on a shaker at 150 rpm for 5 min for a thorough mixing. The optical density was recorded using a microplate reader (Mindray-96A, China.) at 560 nm. The results were corrected using a reference wavelength of 620 nm (wells without adding MTT). All experiments were carried out in triplicate.
Determination of IC50 values
GraphPad Prism version 5 software, Inc., California, U.S.A was used to calculate IC50(the half maximal inhibitory concentration) values of different extracts of C. acutum seeds and doxorubicin (as a positive control) against A549, PC-3, MCF-7, HepG-2, Caco-2, and WI-38. The percentage growth inhibition was calculated using Equation:
The parameters of experiments were conducted, and the results were presented as mean ± standard deviation. The statistical significance of the data obtained from in vitro studies was evaluated by the t-test at P < 0.05, P < 0.001, and P < 0.0001 using Statistical software (GraphPad InStat, Version 3.10, GraphPad Software, Inc. USA).
| Results and Discussion|| |
In the present study, we identify the compounds that were responsible for the anticancer activity of seeds of C. acutum extracts using GC/MS technique to help in chemical profiling and standardization of the extracts. The results of GC/MS analysis revealed that the seeds were found to contain different classes of bioactive secondary metabolites including hydrocarbons, fatty acids, sterols, flavonoids, terpenes, and alkaloids [Table 1] and [Figure 1]. Sesquiterpenoids such as cedrene were detected in the ether extract. The total lipid content of C. acutum seeds reached a value of 12.7 g/100 g seed powder. The major components of unsaturated fatty acids were linoleic acid (RA = 56.71%) in the ether extract and oleic acid (RA = 6.59%) in the chloroform extract. On the other hand, the saturated fatty acids represented about 8.92% in the ether extract, of which palmitic acid has a relative abundance (RA = 3.51%). These fatty acids were reported to have anti-inflammatory and anticancer activity.,, Furthermore, fatty acids, fatty acid ester, and aliphatic alkanes have antimicrobial and cytotoxic effects. Diterpene alcohol and phytol were identified in the ether and chloroform seed extracts, whereas phytol acetate was identified in the aqueous extract (RA = 3.38%). Total phenolic compound and flavonoid contents of seeds of C. acutum were 39 mg gallic acid equivalents per gram dry weight and 25 mg catechin equivalents per gram dry weight, respectively. Flavonoid compound, lucenine 2 (luteolin 6,8-di-C-glucoside), was identified in all seeds extracts, whereas quercetin 7, 3, 4-trimethoxy was identified in both aqueous and chloroform extracts. These flavonoids have antioxidant and anti-inflammatory activities. The sterols, cholestan-3-ol, 2 methylene (RA = 0.30%) and corticosterone (RA = 0.16%) were identified in the chloroform extract. Furthermore, 5α-cholestan-3-one, cyclic ethylene acetate, was identified only in the aqueous extracts. These sterols were reported to have anti-inflammatory effect.
|Table 1: Chemical constituent identification of different extracts of Cynanchum acutum seeds by gas chromatography/mass spectrometry|
Click here to view
|Figure 1: Gas chromatography/mass spectrometry spectra of Cynanchum acutum seeds – (a) ether extract, (b) chloroform extract, and (c) aqueous extract (at full page width)|
Click here to view
The alkaloid content of seeds of C. acutum amounted was 5.26 ± 0.2 mg/g of dried material. Twelve alkaloids were identified in the seeds of C. acutum. Pleiocarpamine, colchifoline, and formyl colchicines were identified in ether extract. However, pseudojervine, 6,7 -dihydroneblininane, and dihydrocorynantheine acetate were identified in the chloroform extract. Finally, 6-carboxypterin, dihydroerysodine, methyladenosine, aspidofractinine-3-methanol, and voacristine hydroxyindolenine were identified in the aqueous extract. However, dihydrovallesiachotamine was identified in the three extracts. The indole alkaloid vallesiachotamine was found to have anticancer and anti-inflammatory effects., Yubin et al. (2014) reported that the separation of the extracted alkaloid depends on alkaloid class, basicity, solubility differences, and the particular functional group. The most detected alkaloid compounds were reported to have an antitumor effect through a different mechanism of actions. The colchicine and its derivatives were found to improve anti-inflammatory activity. Colchifoline and formyl colchicine were reported for the first time in C. acutum and the genus of Cynanchum. Colchifoline was found to be toxic as same as colchicines in the menogaril-resistant mouse leukemia (P388) with a good affinity for tubulin. Formyl colchicines also have anti-inflammatory activity. The alkaloid, pleiocarpamine, is a potential therapeutic agent for Alzheimer's disease. Dihydrocorynantheine was active against Leishmania major. 6-carboxypterin possessed potent antioxidant and anti-inflammatory activities., The steroidal alkaloid, pseudojervine, was reported to possess antitumor and antiplatelet activities.
Aspidofractinine-3-methanol (Kopsinyl alcohol) was reported to possess potent anti-inflammatory and antitumor activities., Tetracyclic alkaloid of erysodine was reported to be an anti-inflammatory and antihypertensive. Voacristine hydroxyindolenine was found to possess significant uterotrophic activity and prevented pregnancy when administered during the preimplantation period in Sprague–Dawley rats.
The anticancer effects of ether, chloroform subfraction, and aqueous extracts of C. acutum seeds were evaluated against lung cancer (A549), PC3, breast cancer (MCF-7), hepatocellular carcinoma (HepG-2), colon cancer (Caco-2), and normal human fetal lung fibroblast (WI-38) cell lines. The seed extracts revealed various anticancer effects against cancer cell lines and cytotoxic effect toward normal cell line [Table 2] and [Figure 2]. The anticancer effects of aqueous and ether extracts on lung cancer (A549) and breast cancer (MCF-7), respectively, were higher than other cell lines. However, the cytotoxic effects of the three extracts toward normal cell lines were reduced. All the IC50 values of the extracts were compared to the IC50 values of a positive control, doxorubicin against the malignant and nonmalignant cell lines. For example, the highest anticancer effect on lung cancer cell lines (A549) was revealed by aqueous extract (IC50 of 115 ± 6 μg/ml), whereas ether extract (IC50 of 1130 ± 7 μg/ml) and chloroform extract (IC50 of 172 ± 22 μg/ml) showed decreased anticancer activities against lung cancer cell lines (A549) comparing to a positive control (IC50 of 100 ± 2 μg/ml). Furthermore, aqueous extract showed low cytotoxic effect (IC50 of 217 ± 21 μg/ml) toward normal cell lines (WI-38) comparing to a positive control (IC50 of 137 ± 10 μg/ml) [Table 2] and [Figure 2]. The highest anticancer effect on breast cancer cell lines (MCF-7) was demonstrated by the ether extract (IC50 of 146 ± 11 μg/ml), whereas the anticancer effects of water extract (IC50 of 152 ± 5 μg/ml) and chloroform extract (IC50 of 192 ± 6 μg/ml) were reduced on breast cancer cell lines (MCF-7) as compared to a positive control (IC50 of 115 ± 7 μg/ml) [Table 2] and [Figure 2]. The cytotoxic effect of ether extract against normal cell lines (WI-38) (IC50 of 209 ± 17 μg/ml) was low compared to a positive control (IC50 of 137 ± 10 μg/ml) [Table 2] and [Figure 2]. Therefore, the major compounds including phytol acetate (RA = 3.38) and aspidofractinine-3-methanol (Kopsinyl alcohol) (RA = 4.05) found in the aqueous extract may possess the potentially highest anticancer effect on lung cancer. Whereas, palmitic acid (RA = 3.51), ethyl linoleate (RA = 25.07), oleic acid (RA = 5.85), and linoleic acid (RA = 56.71) found in the ether extract may be responsible for the highest anticancer effect on lung cancer. However, the other identified compounds in the aqueous and ether extracts showed low RA percentage [Table 1]. Therefore, isolation of these compounds from ether and aqueous extracts of C. acutum seeds and studying their anticancer effects on lung and breast cancers are strongly recommended. Thus, we can verify their potential effect for lung and breast cancer treatments with possibly reduced systemically adverse effects.
|Table 2: Cytotoxic effects of different extract fractions of Cynanchum acutum seeds on cancer cell lines|
Click here to view
|Figure 2: Anticancer effects of different extracts of Cynanchum acutum seeds on cancer cell lines (at full page width)|
Click here to view
| Conclusion|| |
From our results, it can be concluded that C. acutum seeds are abundant sources of several pharmaceutically essential compounds which can be used as sources of new and useful anticancer chemical entities. The aqueous and ether extracts of seeds exhibited anticancer activities against lung cancer and breast cancer, respectively, with a potential safety toward normal cell lines. These anticancer activities may be attributed to the presence of different classes of bioactive compounds such as fatty acids, sterols, flavonoids, and alkaloids. This indicates that aqueous and ether extracts may be considered as potential drugs for lung and breast cancer treatments with reduced their systemic adverse effects. Further isolation and structure clarification of pure compounds which may be responsible for the anticancer activities of C. acutum are needed, and further experiments are warranted to explore their action mechanism.
We want thank of Professor Iman Hussien Salama Al-Gohary, Professor of Plant Taxonomy, Department of Plant Ecology and Range, Herbarium, Desert Research Centre, Cairo, Egypt, for her helping in collecting and identifying the Cynanchum acutum plants.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Abd El Gawad A. Ecology of weeds and invasive plant species in newly reclaimed areas in Nile Delta, Egypt. J Environ Sci 2011;40:69-90.
Sayed S, El Sayed A, Zayed A. Oil spill pollution treatment by sorption on natural Cynanchum acutum
L. plant. J Appl Sci Environ Manag 2003;7:63-73.
Atta A, Nasr SM, Mouneir SM. Antiulcerogenic effect of some plants extracts. Nat Prod Radiance 2005;4:242-3.
Fawzy GA, Abdallah HM, Marzouk MS, Soliman FM, Sleem AA. Antidiabetic and antioxidant activities of major flavonoids of Cynanchum acutum
L. (Asclepiadaceae) growing in Egypt. Z Naturforsch C 2008;63:658-62.
Dehghani M, Ganjali Z, Javadian F, Estakhr J, Heidari A. Anti-microbial activity of ethanolic and aqueous extract of Cynanchum acutum
. Br J Pharmacol Toxicol 2012;3:177-80.
Moustafa SM, Menshawi BM, Wassel GM, Mahmoud K, Mounier M. Screening of some plants in Egypt for their cytotoxicity against four human cancer cell lines. Int J Pharm Tech Res 2014;6:1074-84.
Estakhr J, Javadian F, Ganjali Z, Dehghani M, Heidari A. Anti-diabetic activity of “Cynanchum acutum
” extract in Alloxan-induced diabetic rats. Int J Animal Vet Adv 2012;4:303-5.
Halim A, Zaghloul A, Ebaid K. Lupeol long-chain fatty acid esters and other lipid constituents from Cynanchum acutum
L. fam. Asclepiadaceae. Egypt J Pharm Sci 1990;31:99-105.
Heneidak S, Grayer RJ, Kite GC, Simmonds MS. Flavonoid glycosides from Egyptian species of the tribe Asclepiadeae (Apocynaceae, subfamily Asclepiadoideae). Biochem Syst Ecol 2006;34:575-84.
Mohamed MA, Ahamed WS, Ei-Said MM, Hayen H. New acylated flavonol diglycosides of Cynanchum acutum
. Nat Prod Commun 2008;3:193-8.
El-Demerdash A, Dawidar A, Keshk E, Abdel-Mogib M. Coumarins from Cynanchum acutum
. Rev Latinoamer Quím 2009;37:65-9.
Konda Y, Iguchi M, Harigaya Y, Takayanagi H, Ogura H, Li X, et al
. Hancokinol, a novel triterpene, from Cynanchum hancokianum
. Tetrahedron Lett 1990;31:5315-8.
Lou H, Li X, Zhu T, Li W. Sinapic acid esters and a phenolic glycoside from Cynanchum hancockianum
. Phytochemistry 1993;32:1283-6.
An T, Huang RQ, Yang Z, Zhang DK, Li GR, Yao YC, et al.
Alkaloids from Cynanchum komarovii
with inhibitory activity against the tobacco mosaic virus. Phytochemistry 2001;58:1267-9.
Huang LJ, Wang B, Zhang JX, Yan C, Mu SZ, Hao XJ, et al.
Studies on cytotoxic pregnane sapogenins from Cynanchum wilfordii
. Fitoterapia 2015;101:107-16.
Sun H, Blanford S, Guo Y, Fu X, Shi W. Toxicity and influences of the alkaloids from Cynanchum komarovii
AL. Iljinski (Asclepiadaceae) on growth and cuticle components of Spodoptera litura
Fabricius (Noctuidae) larvae. Nat Prod Res 2012;26:903-12.
Congai Z, Yanyan G, Xuechang Z, Jing M, Wangpeng S. Optimisation of conditions for extracting pesticidal alkaloids from Cynanchum komarovii
(Maxim.). Nat Prod Res 2013;27:23-7.
Zhao YB, Shen YM, He HP, Li YM, Mu QZ, Hao XJ. Carbohydrates from Cynanchum otophyllum
. Carbohydr Res 2004;339:1967-72.
Liu Y, Qu J, Yu SS, Hu YC, Huang XZ. Seven new steroidal glycosides from the roots of Cynanchum forrestii
. Steroids 2007;72:313-22.
Yildiz I, Sen O, Erenler R, Demirtas I, Behcet L. Bioactivity-guided isolation of flavonoids from Cynanchum acutum
L. subsp. sibiricum (willd.) rech. f. and investigation of their antiproliferative activity. Nat Prod Res 2017;31:2629-33.
Youssef AM, El-Swaify ZA, Al-Saraireh YM, Al-Dalain SM. Cytotoxic activity of methanol extract of Cynanchum acutum
L. seeds on human cancer cell lines. Latin Am J Pharm 2018;37:1997-2003.
Yubin J, Miao Y, Bing W, Yao Z. The extraction, separation and purification of alkaloids in the natural medicine. J Chem Pharm Res 2014;6:338-45.
Thabrew MI, Hughes RD, McFarlane IG. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J Pharm Pharmacol 1997;49:1132-5.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
De Morais SM, Do Nascimento JE, De Sousa Silva AA, Junior JE, Pinheiro DC, De Oliveira RV. Fatty acid profile and anti-inflammatory activity of fixed plant oils. Acta Sci Veterinariae 2017;45:1-8.
Park SY, Seetharaman R, Ko MJ, Kim DY, Kim TH, Yoon MK, et al.
Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cells. Int Immunopharmacol 2014;19:253-61.
Solórzano-Santos F, Miranda-Novales MG. Essential oils from aromatic herbs as antimicrobial agents. Curr Opin Biotechnol 2012;23:136-41.
Kim MK, Yun KJ, Lim DH, Kim J, Jang YP. Anti-inflammatory properties of flavone di-C-glycosides as active principles of Camellia
mistletoe, Korthalsella japonica
. Biomol Ther (Seoul) 2016;24:630-7.
Patel SS, Savjani JK. Systematic review of plant steroids as potential antiinflammatory agents: Current status and future perspectives. J Phytopharmacol 2015;4:121-5.
Cao P, Liang Y, Gao X, Li XM, Song ZQ, Liang G. Monoterpenoid indole alkaloids from Alstonia yunnanensis
and their cytotoxic and anti-inflammatory activities. Molecules 2012;17:13631-41.
Nisar A, Mamat AS, Hatim MI, Aslam MS, Syarhabil M. An updated review on Catharanthus roseus
: Phytochemical and pharmacological analysis. Indian Res J Pharm Sci 2016;9:631-53.
Joshi CS, Priya ES, Mathela CS. Isolation and anti-inflammatory activity of colchicinoids from Gloriosa superba
seeds. Pharm Biol 2010;48:206-9.
Al-Snafi AE. Medicinal importance of Colchicum candidum
– A review. Pharm Chem J 2016;3:111-7.
Craig DH, Owen CR, Conway WC, Walsh MF, Downey C, Basson MD. Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice. J Clin Invest 2008;118:3170-80.
Naaz H, Singh S, Pandey VP, Singh P, Dwivedi UN. Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer's disease: An in silico
approach. Indian J Biochem Biophys 2013;50:120-5.
Gutiérrez-Rebolledo GA, Drier-Jonas S, Jiménez-Arellanes MA. Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update. Asian Pac J Trop Med 2017;10:1105-10.
Khyade MS, Waman MB. Chemical profile and antioxidant properties of Mundulea sericea
. Pharmacogn J 2017;9:213-20.
Al-Rubaye AF, Kaizal AF, Hameed IH. Phytochemical screening of methanolic leaves extract of Malva sylvestris
. Int J Pharmacogn Phytochem Res 2017;9:537-52.
Tang J, Li HL, Shen YH, Jin HZ, Yan SK, Liu XH, et al.
Antitumor and antiplatelet activity of alkaloids from Veratrum dahuricum
. Phytother Res 2010;24:821-6.
Kam TS, Subramaniam G, Sim KM, Yoganathan K, Koyano T, Toyoshima M, et al.
Reversal of multidrug resistance (MDR) by aspidofractinine-type indole alkaloids. Bioorg Med Chem Lett 1998;8:2769-72.
Govindaraj S, Renganathan S. Molecular characterization and phytochemical studies of Pleurotus
sp to unveil species diversity and pharmacological activities. J Pure Appl Microbiol 2017;11:891-902.
Lloyd GK, Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther 2000;292:461-7.
Srivastava S, Singh MM, Kulshreshtha DK. A new alkaloid and other anti-implantation principles from Tabernaemontana heyneana
. Planta Med 2001;67:577-9.
[Figure 1], [Figure 2]
[Table 1], [Table 2]